Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function. - Wikidata - awgldk - TriplyDB

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

http://www.wikidata.org/entity/Q34519283

about

Effect of rifaximin on gut microbiota composition in advanced liver disease and its complications Alcoholic liver disease: the gut microbiome and liver cross talk The human laryngeal microbiome: effects of cigarette smoke and reflux.Proton pump inhibitors: Risks of long-term use.Salivary microbiota reflects changes in gut microbiota in cirrhosis with hepatic encephalopathy Gut Microbiota Alterations can predict Hospitalizations in Cirrhosis Independent of Diabetes Mellitus Use of Acid Suppression Medication is Associated With Risk for C. difficile Infection in Infants and Children: A Population-based Study Community-Metabolome Correlations of Gut Microbiota from Child-Turcotte-Pugh of A and B Patients.Global Fecal and Plasma Metabolic Dynamics Related to Helicobacter pylori Eradication.NMR-based metabolomics Reveals Alterations of Electro-acupuncture Stimulations on Chronic Atrophic Gastritis Rats.Immunotherapy in the treatment and prevention of infection in acute-on-chronic liver failure.Fecal Microbiota Transplant from a Rational Stool Donor Improves Hepatic Encephalopathy: A Randomized Clinical Trial.Acid-Suppressive Therapy and Risk of Infections: Pros and Cons.Gut microbiome and liver disease.Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.The 3-month readmission rate remains unacceptably high in a large North American cohort of patients with cirrhosis.HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients.Acid suppression therapy and allergic reactions.The gut microbiome in atherosclerotic cardiovascular disease.Effective and safe proton pump inhibitor therapy in acid-related diseases - A position paper addressing benefits and potential harms of acid suppression Gastric acid suppression promotes alcoholic liver disease by inducing overgrowth of intestinal Enterococcus.Decompensated cirrhosis and microbiome interpretation.Microbiota, cirrhosis, and the emerging oral-gut-liver axis.Salivary microbiota-immune profiling in cirrhosis: could this be the noninvasive strategy that will revolutionize prognostication in hepatology?Systematic review: human gut dysbiosis induced by non-antibiotic prescription medications.Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES.Risk of Subsequent Sepsis within 90 Days of a Previous Hospital Stay by Type of Antibiotic Exposure.Macrophage-Mediated Clofazimine Sequestration Is Accompanied by a Shift in Host Energy Metabolism.Gut microbial RNA and DNA analysis predicts hospitalizations in cirrhosis.Protein interaction mapping interpretation of none alcoholic fatty liver disease model of rats after fat diet feeding.Safe use of proton pump inhibitors in patients with cirrhosis.Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis Alterations in gut microbial function following liver transplant Clinical impact of microbiome in patients with decompensated cirrhosis

P2860

Q26775927-DF872A2B-6582-495D-AC50-DAD2FFDCA15D Q27025627-00AB55A0-4A14-460C-A3D7-3948F8FA605D Q30826002-B38BC858-E339-4495-A6FF-CBC9E9545419 Q34549406-9C5444D7-53F6-460F-9891-7AA205FC32AD Q35589590-D3807313-6CCA-47D3-AB19-06104D2E8A95 Q35875078-E8D426E1-04CF-4F82-9546-C2F53B4E177E Q35999704-435DD39D-7C1C-415C-A343-202B9E475714 Q37416188-A5BDA6AE-F145-4A78-9B8C-D48F2050EDDD Q37727592-30BA2126-30C6-43EF-B740-AC6DC019A6CE Q37728743-DF920FD9-6B6C-464A-B154-68D274EF3236 Q38524991-62E52B8B-590C-4062-924B-C3BB752F0B93 Q38740977-3C277920-4880-4FF3-8A98-53E13958EA68 Q38865456-3F867594-45BC-4B12-A24E-D4B4154C214E Q38914215-BE624E60-E7C2-497B-83E6-7D8224133E52 Q39542998-ABB03CD4-D7DE-4D83-8611-615553B83D3C Q40185640-64DABFC7-AF3F-4532-95B6-016DA2C03E46 Q40612995-89AB8643-66CA-40DA-A489-7792AA325B6F Q42024011-226024B4-1418-4EA1-A210-B8BF76B06064 Q42265319-2CFF7B47-5C57-4912-A431-34EEFBABEA2C Q42371575-1AC350FA-4A24-43D4-926D-D0848F3E8A0B Q42378987-7C29C612-58D2-48FE-9395-EDE67B6696F4 Q43204427-797AF7E6-445B-431B-8BA0-1441EAC5EA68 Q45069266-43D14FD4-91EC-4E98-A3AD-FE25B549AD0E Q46725701-2CEEE2EF-596B-443A-B9AF-D3B9562AFB04 Q47283908-3FCA42F3-AF64-4CB6-85BF-09E0372F0D88 Q47590039-AE258B64-A53B-4907-B241-4E9CFE647814 Q47599691-5AE9DB66-8A71-40CF-AD8B-54DDF9B969CC Q52677571-09C18605-A30F-42E9-9126-040507A7E7C4 Q54260378-C02EB370-CC00-4397-8E26-4023BBAC7945 Q55034297-88EE8AC3-D4A7-4295-9C96-BED4D5D8F8E2 Q55718075-196544BA-8E3E-446A-B2EC-95A18A8225EE Q57063286-6995BE77-142C-412B-A3C9-9FBB74668CD3 Q57118481-BE99C182-D98D-4516-A89E-B97AD14B51C9 Q58740370-EEE4B255-A545-44BF-A6D8-1D898C50BE61

P2860

Systems biology analysis of omeprazole therapy in cirrhosis demonstrates significant shifts in gut microbiota composition and function.

http://www.wikidata.org/entity/Q34519283

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Systems biology analysis of om ...... iota composition and function.

@ast

Systems biology analysis of om ...... iota composition and function.

@en

Systems biology analysis of om ...... iota composition and function.

@nl

type

label

Systems biology analysis of om ...... iota composition and function.

@ast

Systems biology analysis of om ...... iota composition and function.

@en

Systems biology analysis of om ...... iota composition and function.

@nl

prefLabel

Systems biology analysis of om ...... iota composition and function.

@ast

Systems biology analysis of om ...... iota composition and function.

@en

Systems biology analysis of om ...... iota composition and function.

@nl

P1433

Q34519283-5EE3D227-51F8-4EFD-8AFE-828F66E2FB5D

P1476

Q34519283-D220011E-99EB-48D8-BDDE-C903749A0817

P2093

Q34519283-08FA373E-A6C3-4DE0-A004-529B7C6E9CA7

Q34519283-0CBBBC68-4324-453C-85EA-E143ADD64ADD

Q34519283-3CD17368-8FFC-4A7F-9A12-217396233454

Q34519283-478B7FF6-48FF-456F-BF39-43E74D98A80D

Q34519283-4C6B5D85-650D-41EB-8A27-4AD9EF9B10D6

Q34519283-4E0E84CE-A800-4F27-A279-83FB907598D7

Q34519283-69C32167-923A-48C2-BA2D-A17B99601EB4

Q34519283-9E9BE229-81DA-4F3E-9CD7-7C702BCE79B1

Q34519283-A01C41D0-D1B9-48D8-B23D-9FC8595B6A1E

Q34519283-B0CF8228-F911-4284-B273-B7261D8E5BE6

P2860

Q34519283-0F3EFA2C-7F74-41B9-9DFB-928384B5DEC3

Q34519283-138AEBA0-E442-4CA4-938F-EBDD1B976081

Q34519283-243B1A11-6EDE-414A-8294-3E0F93DFACD8

Q34519283-2F5AC23A-E9DB-494B-BA38-003604967DE6

Q34519283-30EFC309-99DC-4905-A79D-EE0551A7DE7A

Q34519283-31EBE0D1-C577-49D0-AD71-5A0D53DEFAF1

Q34519283-3622FAC6-2D02-442B-816D-6061335C7C33

Q34519283-3F9F6229-444D-48CD-9FF6-2C37BCFF2821

Q34519283-4BD9F39B-4FF1-46C5-82C6-50A706EBF18E

Q34519283-585896BC-B69F-4A20-A97B-4D8925D0A8D3

P304

Q34519283-D4120715-22C4-4B3B-A3D8-46A99E4D2F07

P31

Q34519283-68A89F76-B114-4200-AE51-D1A03584B234

P356

Q34519283-10B165FB-5E89-46D2-828C-434177715716

P433

Q34519283-2B938F0A-C8E5-4254-A923-FB84F81AFB14

P478

Q34519283-22D0878C-748A-4DE3-ACBB-3169D462CDC9

P50

Q34519283-0048CFC7-22C3-4292-B576-C028B8545384

P577

Q34519283-DDF04486-45DA-4ADA-8299-D452839DB73E

P5875

Q34519283-449304D1-D240-4CCC-8942-282438CE92B4

P698

Q34519283-EF7BD5F4-8BB1-4409-9275-679687BA6684

P932

Q34519283-01C63891-45C5-4F2D-8739-DDE79DC3F8C9

P356

AJPGI.00268.2014

P1433

American Journal of Physiology - Gastrointestinal and Liver Physiology

P1476

Systems biology analysis of om ...... iota composition and function.

@en

P2093

Douglas M Heuman

http://www.w3.org/2001/XMLSchema#string

Jasmohan S Bajaj

http://www.w3.org/2001/XMLSchema#string

Kalyani Daita

http://www.w3.org/2001/XMLSchema#string

Maiyuran Ratneswaran

http://www.w3.org/2001/XMLSchema#string

Mary M E Crossey

http://www.w3.org/2001/XMLSchema#string

Masoumeh Sikaroodi

http://www.w3.org/2001/XMLSchema#string

Melanie B White

http://www.w3.org/2001/XMLSchema#string

Mitchell L Schubert

http://www.w3.org/2001/XMLSchema#string

Naga S Betrapally

http://www.w3.org/2001/XMLSchema#string

Nicole A Noble

http://www.w3.org/2001/XMLSchema#string

P2860

Cytoscape: a software environment for integrated models of biomolecular interaction networks

HMDB 3.0--The Human Metabolome Database in 2013

Saliva from obese individuals suppresses the release of aroma compounds from wine

Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients

Statistical methods for detecting differentially abundant features in clinical metagenomic samples.

Differences in gut microbial metabolism are responsible for reduced hippurate synthesis in Crohn's disease

The human oral microbiome.

Increased rate of spontaneous bacterial peritonitis among cirrhotic patients receiving pharmacologic acid suppression.

Cometabolism of microbes and host: implications for drug metabolism and drug-induced toxicity.

Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors.

P304

G951-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPGI.00268.2014

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

307

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-09-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

266245598

http://www.w3.org/2001/XMLSchema#string

P698

25258407

http://www.w3.org/2001/XMLSchema#string

P932

4233285

http://www.w3.org/2001/XMLSchema#string